Skip to main content
Premium Trial:

Request an Annual Quote

Roche, HTG Partner on Gene Expression Technologies

NEW YORK (GenomeWeb News) – Roche announced today that its Roche NimbleGen business will collaborate with High Throughput Genomics on gene expression applications.

Under the pact, Roche NimbleGen will provide HTG with high-density, multiplex DNA microarray slides. HTG will apply its quantitative nuclease protection assay process to the arrays to enable researchers to rapidly measure gene expression levels in a variety of sample types.

The firms said that sample preparation using the qNPA technology enables simpler and more cost-effective workflow compared to traditional labeling methods.

"Roche NimbleGen was able to offer us unique and differentiated array synthesis and formatting capabilities that best meet our client needs," T.J. Johnson, president and CEO of Tucson, Az.-based HTG, said in a statement. "The combination of low cost, flexibility, and high throughput means HTG's customers can derive substantial benefits quickly and we can increase the plex in the analysis process as needed."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.